FEASIBILITY OF ELBASVIR/GRAZOPREVIR FOR TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTION IN RENAL TRANSPLANT RECIPIENTS WITH IMPAIRED ALLOGRAFT FUNCTION

被引：0
|
作者：
Eisenberger, U. [1 ]
Friebus-Kardash, J. [1 ]
Guberina, H. [2 ]
Kribben, A. [1 ]
Witzke, O. [2 ]
Achterfeld, A. [3 ]
Gerken, G. [3 ]
Herzer, K. [3 ,4 ]
机构：
[1] Univ Klin Essen, Nephrol, Essen, Germany
[2] Univ Klin Essen, Infektiol, Essen, Germany
[3] Univ Klin Essen, Gastroenterol, Essen, Germany
[4] Univ Klin Essen, Abdominal & Transplantat Chirurg, Essen, Germany
来源：
TRANSPLANT INTERNATIONAL | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P01
引用
收藏
页码：28 / 28
页数：1
相关论文
共 50 条
  • [1] Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function
    Eisenberger, Ute
    Friebus-Kardash, Justa
    Guberina, Hana
    Kribben, Andreas
    Witzke, Oliver
    Willuweit, Katharina
    Gerken, Guido
    Herzer, Kerstin
    TRANSPLANTATION DIRECT, 2019, 5 (01):
  • [2] TREATMENT WITH GRAZOPREVIR/ELBASVIR FOR RENAL TRANSPLANT RECIPIENTS WITH CHRONIC HEPATITIS C VIRUS INFEKTION AND IMPAIRED ALLOGRAFT FUNCTION
    Eisenberger, Ute
    Friebus-Kardash, Justa
    Rohn, Hana
    Kribben, Andreas
    Witzke, Oliver
    Gaeckler, Anja
    Willuweit, Katharina
    Gerken, Guido
    Herzer, Kerstin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [3] Elbasvir/grazoprevir for treatment of chronic hepatitis C virus infection
    Chandana Papudesu
    Shyamasundaran Kottilil
    Shashwatee Bagchi
    Hepatology International, 2017, 11 : 152 - 160
  • [4] Elbasvir/grazoprevir for treatment of chronic hepatitis C virus infection
    Papudesu, Chandana
    Kottilil, Shyamasundaran
    Bagchi, Shashwatee
    HEPATOLOGY INTERNATIONAL, 2017, 11 (02) : 152 - 160
  • [5] Erratum to: Elbasvir/grazoprevir for treatment of chronic hepatitis C virus infection
    Chandana Papudesu
    Shyamasundaran Kottilil
    Shashwatee Bagchi
    Hepatology International, 2017, 11 : 315 - 316
  • [6] Grazoprevir + elbasvir for the treatment of hepatitis C virus infection
    Alric, Laurent
    Bonnet, Delphine
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (05) : 735 - 742
  • [7] Grazoprevir/Elbasvir Treatment in Liver or Kidney Transplant Recipients with Genotype 1b Hepatitis C Virus Infection
    Lai, Ping-Chin
    Chen, Cheng-Hsu
    Jeng, Long-Bin
    Yu, Tung-Min
    Tsai, Shang-Feng
    Wu, Ming-Ju
    Cheng, Shao-Bin
    Yang, Sheng-Shun
    Lee, Teng-Yu
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (02)
  • [8] Elbasvir/Grazoprevir (Zepatier) for Hepatitis C Virus Infection
    Early, Jessica
    Maxted, George
    AMERICAN FAMILY PHYSICIAN, 2017, 95 (06) : 393 - 394
  • [9] EFFECTIVENESS OF ELBASVIR/GRAZOPREVIR ± SOFOSBUVIR IN POST SOLID ORGAN TRANSPLANT PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
    Ajlan, Aziza
    Ahmed, Mohamed
    Abu-Riash, Tamadhor
    Alkortas, Delal
    Alabdulkarim, Zinah
    Aljedai, Ahmed H.
    HEPATOLOGY, 2019, 70 : 980A - 980A
  • [10] Grazoprevir/elbasvir for treatment of hepatitis C virus genotype 4 post kidney transplant
    Abaalkhail, Faisal
    Hasan, Hazem
    Elsiesy, Hussien
    Alhamoudi, Waleed
    JOURNAL OF HEPATOLOGY, 2020, 73 : S338 - S338
12345